The ARV-825 Diaries

trastuzumab deruxtecan, pazopanib. Possibly improves toxicity of another by immunosuppressive consequences; chance of infection. Use Warning/Watch. Neutropenia or febrile neutropenia incidence were enhanced when trastuzumab was coadministered with myelosuppressive chemotherapy. . Monitor Intently
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15